- Home
- DNLI vs AIN Comparison
DNLI vs AIN Comparison
Compare DNLI & AIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNLI
- AIN
- Stock Information
- Founded
- DNLI 2013
- AIN 1895
- Country
- DNLI United States
- AIN United States
- Employees
- DNLI N/A
- AIN N/A
- Industry
- DNLI Biotechnology: Biological Products (No Diagnostic Substances)
- AIN Textiles
- Sector
- DNLI Health Care
- AIN Consumer Discretionary
- Exchange
- DNLI Nasdaq
- AIN Nasdaq
- Market Cap
- DNLI 3.1B
- AIN 2.5B
- IPO Year
- DNLI 2017
- AIN 1987
- Fundamental
- Price
- DNLI $20.73
- AIN $79.93
- Analyst Decision
- DNLI Strong Buy
- AIN Buy
- Analyst Count
- DNLI 13
- AIN 4
- Target Price
- DNLI $37.91
- AIN $80.75
- AVG Volume (30 Days)
- DNLI 814.8K
- AIN 119.7K
- Earning Date
- DNLI 03-04-2025
- AIN 02-26-2025
- Dividend Yield
- DNLI N/A
- AIN 1.32%
- EPS Growth
- DNLI N/A
- AIN 1.31
- EPS
- DNLI N/A
- AIN 3.20
- Revenue
- DNLI N/A
- AIN $1,267,294,000.00
- Revenue This Year
- DNLI N/A
- AIN $9.50
- Revenue Next Year
- DNLI $289.18
- AIN $4.06
- P/E Ratio
- DNLI N/A
- AIN $25.76
- Revenue Growth
- DNLI 204.74
- AIN 15.93
- 52 Week Low
- DNLI $14.56
- AIN $67.39
- 52 Week High
- DNLI $33.33
- AIN $98.73
- Technical
- Relative Strength Index (RSI)
- DNLI 42.56
- AIN 45.95
- Support Level
- DNLI $21.33
- AIN $79.16
- Resistance Level
- DNLI $22.81
- AIN $82.95
- Average True Range (ATR)
- DNLI 1.27
- AIN 1.81
- MACD
- DNLI -0.10
- AIN 0.05
- Stochastic Oscillator
- DNLI 15.83
- AIN 38.93
About DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.
About AIN Albany International Corporation
Albany International Corp is principally engaged in processing textiles and materials. The company consists of two business segments, the machine clothing segment, which produces and provides custom-designed fabrics and belts for the production in the paper, nonwovens, and other process industries; and the Albany engineered composites segment, which offers engineered composite parts for the aerospace and defensive industries. The machine clothing segment contributes to the majority of the company's total revenue. The company has an operation and generates revenue from the United States, Switzerland, Brazil, China, Mexico, France, and other areas.